S. cerevisiae studies have been instrumental in understanding the role HOPS subunits have in regulating tethering, SNARE pair formation, and fusion of organelles with the vacuolar compartment.
1,
3–
5,
7–
9,
12–
15,
26–
42 Metazoan genetic deficiencies are consistent with the role of the HOPS complex in the delivery of vesicle contents to lysosomes and lysosome-related organelles. However, the existence of HOPS subunit isoforms, metazoan-specific HOPS subunits, such as SPE-39, as well as partially overlapping distribution or function of HOPS subunits along the endocytic route suggest a more complex picture in metazoans than in yeast.
43–
47 Vps33 exists as two isoforms (a and b) encoded by different genes in
C. elegans, Drosophila melanogaster and
Homo sapiens. Vps33A and Vps33B are not redundant in Drosophila suggesting distinct tissue and possibly organellar functions.
48 Moreover, the
Hermansky-
Pudlak
syndrome (HPS) and
Arthrogryposis,
Renal Dysfunction and
Cholestasis (ARC), affecting Vps33a and Vps33b respectively, further support this idea in mammals. HPS is characterized by occulocutanoeous pigment dilution, prolonged bleeding, and pulmonary fibrosis.
49–
51 Symptoms of HPS arise from defects in sorting to lysosomes and lysosome-related organelles such as the melanosome and platelet dense granules.
49,
50,
52 In humans, a subset of HPS patients displays mutations to the gene encoding the β subunit of AP-3.
53,
54 Models for HPS have been discovered in mouse and Drosophila.
53,
54 In mice, mutations to the genes that encode the clathrin adaptor AP-3 subunits AP-3 β1 and AP-3 δ1 as well as the class C HOPS subunit Vps33a result in decreased coat color, prolonged bleeding, and defects in lysosomal protein targeting.
49,
52,
55,
56 Drosophila homologs of class B and C HOPS subunits Vps33a, Vps41, Vps18, and adaptor protein AP-3 subunits also result in pigmentation defects.
48,
52,
57–
61 Importantly, mammalian phenotypes in AP-3 and Vps33a deficiencies are distinct from those of patients carrying mutations in Vps33b, a defect that leads to the ARC syndrome. ARC results from mutations to the gene responsible for encoding the class C HOPS subunit Vps33b or the Vps33b-interacting protein SPE-39, which is absent in yeast.
46,
62,
63 Spe39 is also referred as VIPAR in
Homo sapiens, a nomenclature that we have disputed.
62,
64 In Drosophila SPE-39 is known as Vps16b
65 despite evidence indicating that SPE-39 possesses unique domains not present in Vps16.
45,
46 SPE-39 robustly immunoprecipitates Vps16,
46 thus suggesting that rather than a Vps16 isoform, SPE-39 is an additional component of class C Vps complexes such as HOPS and a putative mammalian CORVET complex (). Patients with ARC syndrome display a variety of phenotypes including severe contracture of joints referred to as arthrogryposis, defects in renal function, cholestasis, bleeding disorders, dry, thickened, scaly or flaky skin referred to as ichthyosis, defects in metabolic absorption, absence or severe size decrease of the corpus callosum and defective organization of the anterior horn of the spinal cord.
62,
63,
66–
84 Importantly, severe joint contracture in patients with ARC syndrome results from a neurological defect as opposed to muscular defects.
63,
75,
80 Analysis of ichthyosis in ARC patients suggests defects in lamellar body secretion as shown by increased amounts of lamellar granules in patients with ARC syndrome by electron microscopy.
68,
69,
72 Kidney epithelial cells and hepatocytes show a loss of apically targeted proteins.
71 All of these phenotypes are consistent with a role for Vps33b and SPE-39 in regulation of lysosome-related organelles and secretion in polarized mammalian cell types. Thus, differences between HPS and ARC phenotypes affecting isoforms of class C Vps proteins may reflect differential tissue distribution of Vps33 isoforms. Alternatively, Vps33 isoforms expressed in the same cell may mediate either distinct tethering events between organelles and target membranes whose identities are specified by Vps33a, Vps33b, and SPE-39 and/or differences in cargoes trafficked by SPE-39-, Vps33a-, or Vps33b-dependent mechanisms.
Signaling receptors are attractive cargo candidates for explanation of phenotypic differences in HPS and ARC patients. For example, epidermal growth factor and Notch receptor degradation are impaired in HOPS complex deficiencies.
46,
85 Notch signaling is critical for embryonic development of neural and epidermal tissues and in the adult Notch modulates synaptic plasticity.
86,
87 Notch regulation could contribute to the severe neuronal and neuromuscular symptoms in patients with ARC syndrome. In the canonical Notch signaling pathway, Notch binds extracellular ligands and undergoes cleavage at the extra- and intracellular domains.
85,
86 Following cleavage, the intracellular domain is transported to the nucleus where it regulates gene expression.
85,
86 In addition, there is an endosomal pathway for Notch activation where Notch receptor is internalized in the absence of extracellular ligand.
85 Internalized Notch is targeted into intraluminal vesicles in multi-vesicular bodies where receptor degradation terminates signaling.
85 However in the endosomal pathway, which is AP-3- and HOPS-dependent, Notch is sorted away from intralumenal vesicles and remains at the multi-vesicular body limiting membrane for delivery to lysosomes where the intracellular domain undergoes cleavage and translocates to the nucleus.
85,
86 The proposed role of HOPS subunits in this study was in regulating the fusion of late endosomes with the lysosome.
85 Such a model is consistent with the presence of HOPS in late endosomes, as demonstrated in yeast
88 and mammalian cells (see below). In such a model an AP-3 pool localized to incoming vesicles would encounter HOPS complexes present in late endosomes resulting in fusion of AP-3 vesicles with late endosomes (see ).
28,
88,
89 An alternative yet not exclusive view, considers that since HOPS and AP-3 interact
28,
47,
88–
90 and AP-3 and HOPS are present in vesicle carriers
47 (), perhaps the HOPS complex subunits may regulate Notch receptor sorting away from multivesicular bodies, to AP-3-HOPS clathrin-coated vesicles for delivery to lysosomes.